CS­tone Pharma hires Richard Yeh as CFO

BioSpectrum (Asia) - - People News -

CS­tone Phar­ma­ceu­ti­cals, a bio­phar­ma­ceu­ti­cal com­pany de­voted to de­vel­op­ing a new gen­er­a­tion of in­no­va­tive drugs, re­cently an­nounced the ap­point­ment of Richard Yeh as Chief Fi­nan­cial Of­fi­cer (CFO), reporting to Dr Frank Jiang, Chief Ex­ec­u­tive Of­fi­cer of CS­tone. Yeh brings vast and deep ex­pe­ri­ence in the phar­ma­ceu­ti­cal and biotech­nol­ogy fi­nance sec­tors and will pro­vide a strong ad­di­tion to CS­tone’s se­nior lead­er­ship ranks. As the CFO of CS­tone, Yeh will de­velop cor­po­rate fi­nan­cial strate­gies, and over­see fi­nan­cial reporting, risk man­age­ment, fund­ing, and IPO. His in-depth un­der­stand­ing of the in­dus­try will help fur­ther ce­ment CS­tone’s po­si­tion among lead­ing in­no­va­tive bio­phar­ma­ceu­ti­cal com­pa­nies in China. Prior to join­ing CS­tone, Yeh was the managing director and the busi­ness unit leader of Asia Pa­cific Health­care eq­uity re­search at Gold­man Sachs. He led the firm’s re­search ef­forts on the Chi­nese and Asia health­care mar­ket. Be­fore that, Yeh served as the head of the re­gional health­care re­search team at Cit­i­group.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.